Secondary progressive multiple sclerosis, or SPMS, already comes with enough medical vocabulary to fill a very unexciting game of Scrabble. Then a neurologist may add another description: active or inactive.
Those words matter because they describe whether multiple sclerosis is currently showing signs of inflammatory activity, such as a relapse or new damage on an MRI. They can influence treatment decisions, monitoring schedules, insurance discussions, and the questions worth bringing to a medical appointment.
However, “inactive” does not mean that MS has disappeared, and “active” does not automatically mean that someone is rapidly becoming more disabled. Disease activity and disability progression are related, but they are not identical. MS, apparently unimpressed by tidy filing systems, can produce one without the other.
What Is Secondary Progressive Multiple Sclerosis?
Multiple sclerosis is a chronic disease of the central nervous system, which includes the brain, spinal cord, and optic nerves. The immune system mistakenly attacks myelin, the protective covering around nerve fibers. Damage to myelin and the underlying nerve tissue can interfere with signals traveling between the brain and the rest of the body.
Many people are initially diagnosed with relapsing-remitting multiple sclerosis, or RRMS. During this phase, clearly defined attacks of new or worsening symptoms are followed by periods of partial or complete recovery.
SPMS develops when the disease course changes and neurological disability begins to worsen more gradually over time. Relapses may continue, become less frequent, or stop entirely. Symptoms may stabilize temporarily, but the overall pattern is one of accumulating difficulty rather than repeated attacks followed by dependable recovery.
The transition from RRMS to SPMS is not always marked by a dramatic announcement. There is no alarm bell, confetti cannon, or single laboratory result that declares, “Congratulations, your disease course has changed.” Doctors usually identify the transition retrospectively by reviewing symptoms, neurological examinations, functional tests, relapse history, and MRI results over time.
What Is Active SPMS?
Active secondary progressive MS means that a person has SPMS and has shown recent evidence of inflammatory MS activity. That evidence may include:
- One or more clinical relapses
- New lesions on a follow-up MRI
- Existing MRI lesions that have enlarged
- Lesions that enhance after gadolinium contrast, suggesting current inflammation
Activity is assessed during a defined period, commonly the previous year, although the exact window can vary among clinicians, studies, and treatment policies. The classification is not a permanent tattoo. Someone may have active SPMS one year and inactive SPMS later, or activity may return after a quiet period.
What counts as an MS relapse?
A true relapse generally involves new neurological symptoms or a clear worsening of previous symptoms lasting at least 24 hours, separated from an earlier attack, and not explained by fever, infection, or another medical problem.
For example, new vision loss, weakness, numbness, coordination problems, or bladder dysfunction may represent a relapse. A clinician should evaluate these changes because not every bad symptom day is caused by fresh MS inflammation.
Heat, poor sleep, emotional stress, urinary tract infections, and other illnesses can temporarily aggravate old symptoms. This is sometimes called a pseudo-relapse or pseudo-exacerbation. It can feel thoroughly real and thoroughly unpleasant, but it does not necessarily mean that new nervous-system damage is occurring.
What Is Inactive SPMS?
Inactive SPMS, sometimes called non-active or nonrelapsing SPMS, means that no clinical relapses and no new inflammatory MRI activity have been identified during the period under review.
This label is frequently misunderstood. Inactive SPMS does not necessarily mean:
- The disease has stopped permanently
- Existing symptoms have gone away
- The person no longer needs neurological care
- Disability cannot continue to increase
- Future relapses or MRI changes are impossible
A person with inactive SPMS may still notice slower walking, worsening balance, increasing stiffness, reduced hand coordination, cognitive changes, bladder problems, or greater difficulty recovering after physical activity. These changes may reflect progression that occurs independently of obvious relapses.
Activity and Progression Are Two Separate Descriptions
Modern MS terminology evaluates two questions:
- Is the disease active? This is determined by relapses or new MRI activity.
- Is disability progressing? This is determined by gradual, confirmed worsening of neurological function.
That creates four possible descriptions:
| SPMS description | What it may look like |
|---|---|
| Active, with progression | Relapses or new MRI lesions occur while everyday neurological function also gradually worsens. |
| Active, without progression | Inflammatory activity is present, but no confirmed gradual disability increase has been measured during the review period. |
| Inactive, with progression | No relapses or new MRI lesions are found, yet walking, coordination, cognition, or another function continues to decline. |
| Inactive, without progression | No inflammatory activity or confirmed disability increase is identified during the review period. |
These categories describe a period of time, not a person’s entire future. Regular reassessment matters because the disease course can change.
How Doctors Determine Whether SPMS Is Active
Reviewing relapses
The neurologist will ask about new symptoms, when they began, how long they lasted, whether they affected daily activities, and whether an infection or fever was present. Keeping a symptom diary can help separate a distinct neurological event from ordinary fluctuations.
Comparing MRI scans
Brain and sometimes spinal cord MRI scans are compared with earlier imaging. Doctors look for new or enlarging T2 lesions and, when contrast is used, gadolinium-enhancing lesions.
An MRI is useful, but it is not an all-knowing crystal ball. Conventional scans are better at detecting focal inflammatory lesions than explaining every mechanism behind progressive disability. Someone can experience meaningful progression even when a routine MRI looks unchanged.
Measuring neurological function
Monitoring may include a neurological examination and standardized tests of:
- Walking speed and endurance
- Balance and risk of falling
- Hand and arm coordination
- Muscle strength and stiffness
- Vision
- Cognitive processing speed
- Speech and swallowing
- Bladder and bowel function
Patient reports are important, too. A timed walking test may change only slightly, while the person reports that grocery shopping now requires two recovery days. Both pieces of information belong in the clinical picture.
Symptoms of Active and Inactive SPMS
Active and inactive SPMS can cause many of the same chronic symptoms. The distinction is based on recent inflammatory activity, not on a unique symptom checklist.
Possible symptoms include:
- Fatigue that is out of proportion to the activity performed
- Muscle weakness or heaviness
- Spasticity, stiffness, or painful spasms
- Difficulty walking or climbing stairs
- Foot drop
- Poor balance or frequent falls
- Numbness, tingling, burning, or nerve pain
- Blurred or double vision
- Bladder, bowel, or sexual dysfunction
- Problems with memory, attention, or processing speed
- Speech or swallowing difficulty
- Depression, anxiety, or emotional changes
In active SPMS, a person may experience a recognizable attack on top of chronic symptoms. In inactive SPMS, changes are more likely to appear as a gradual erosion of function. The coffee mug becomes harder to carry. The walk from the parking lot feels longer. A task that once took 20 minutes now requires an hour and a strategic relationship with the nearest chair.
How Active SPMS Is Treated
Several disease-modifying therapies, or DMTs, are approved in the United States for relapsing forms of MS, a category that includes active SPMS. These medications primarily target inflammatory activity. Their goals may include reducing relapses, limiting the development of new lesions, and lowering the risk of additional disability.
Siponimod is notable because it was specifically evaluated in a large SPMS clinical trial. Other therapies approved for relapsing MS may also be considered for active SPMS. The best option depends on factors such as:
- Recent relapse and MRI history
- Previous treatments and their effectiveness
- Age and level of disability
- Infection risk
- Heart, liver, immune-system, and other health conditions
- Pregnancy plans
- Medication risks, monitoring requirements, and personal preferences
High-dose corticosteroids may be used to shorten a significant relapse. They may help recovery happen faster, but they do not reverse SPMS or reliably change long-term progression.
A person should never stop, restart, or switch a DMT without guidance from an MS specialist. Some medications can cause rebound disease activity when stopped abruptly, while others require laboratory testing, vaccinations, or a carefully planned transition.
How Inactive SPMS Is Treated
Treatment for inactive SPMS is more complicated because most currently available DMTs were designed to suppress focal inflammation. When there are no relapses or new inflammatory lesions, the potential benefit of continuing an immune-targeting medication may be smaller, while risks such as infection can increase with age, disability, and treatment duration.
As of July 2026, the FDA has not approved a medication specifically for non-active SPMS. Tolebrutinib was studied as a possible treatment for nonrelapsing SPMS, but it did not receive U.S. approval after the FDA identified serious liver-safety concerns and uncertainty about its benefit-risk profile.
This does not mean that inactive SPMS is untreatable. It means that care often shifts toward preserving function, controlling symptoms, preventing complications, and reassessing whether a DMT still offers enough benefit to justify its risks.
A neurologist may discuss continuing, changing, de-escalating, or discontinuing a DMT. The decision should be individualized rather than based on the word “inactive” alone. Age, recent MRI stability, time since the last relapse, mobility, other medical conditions, and the specific drug all matter.
Rehabilitation and Symptom Care Matter in Both Types
DMT decisions tend to attract the spotlight, but symptom management and rehabilitation often produce the most noticeable improvements in daily life.
Physical therapy
A physical therapist familiar with neurological conditions can address strength, balance, gait, endurance, spasticity, and fall prevention. The goal is not to exhaust a weakened muscle until it files a formal complaint. Exercise should be adapted to the person’s abilities, temperature sensitivity, and recovery needs.
Occupational therapy
Occupational therapists help make daily activities safer and less tiring. They may recommend changes to the home, workplace, bathroom, kitchen, computer setup, or routine. Mobility aids and adaptive equipment are tools for independence, not evidence of failure.
Speech and swallowing therapy
A speech-language pathologist can evaluate speech clarity, voice strength, cognitive communication, and swallowing. Early evaluation is especially important if coughing, choking, unexplained weight loss, or recurrent respiratory infections occur.
Targeted symptom treatment
Medications and behavioral strategies may help manage spasticity, nerve pain, fatigue, bladder urgency, constipation, sleep problems, depression, and other symptoms. Treating infections, sleep apnea, anemia, thyroid disorders, medication side effects, and cardiovascular risk factors may also improve function.
Healthy routines
Regular movement, adequate sleep, smoking cessation, appropriate vaccinations, balanced nutrition, and management of other health conditions support overall health. No single diet, supplement, or heroic smoothie has been proven to stop SPMS. Supplements should be discussed with a clinician because “natural” and “risk-free” are not synonyms.
Questions to Ask an MS Specialist
- Do you consider my SPMS active or inactive, and what evidence supports that description?
- What time period are you using to assess activity?
- Am I showing confirmed disability progression?
- How do my latest MRI scans compare with previous scans?
- What is the goal of my current DMT?
- How will we determine whether the treatment is helping?
- What are the risks of continuing, switching, or stopping it?
- Should my walking, hand function, or cognition be formally tested?
- Would physical, occupational, speech, or pelvic-floor therapy help?
- Which symptoms should prompt an urgent call?
Experiences of Living With Active or Inactive SPMS
The following examples are fictional composites based on commonly reported SPMS experiences. They do not describe specific patients and should not be treated as medical predictions.
Experience 1: A quiet year interrupted by a new symptom
Imagine a person who has been living with SPMS for several years. Walking has slowly become harder, but the previous MRI was stable and there had been no clear relapse for more than a year. Then one morning, vision in the right eye becomes noticeably dimmer. The change lasts for several days and cannot be explained by fever or infection.
An examination and new MRI show inflammatory activity. The person’s SPMS may now be described as active, even though it had recently been considered inactive. The neurologist reviews the current treatment and discusses whether a different DMT could better control inflammation.
The emotional reaction may be mixed. New activity is unwelcome, but it also gives the care team a clearer target. There is evidence to act on rather than a vague sense that something is changing behind the scenes.
Experience 2: No relapses, but the stairs keep getting taller
Another person has no new lesions and no recognizable attacks. Yet over 18 months, climbing stairs changes from inconvenient to nearly impossible. The person begins using a cane outdoors and avoids carrying laundry between floors.
This pattern may represent inactive SPMS with progression. Because the MRI is unchanged, friends may assume that the disease is stable. The person may even wonder whether the worsening is “real enough” to mention.
It is real enough. Neurological progression is not required to pose dramatically for an MRI. Tracking walking time, falls, activity tolerance, hand function, and changes in daily routines can help the medical team document progression and recommend rehabilitation or equipment.
Experience 3: Stable does not mean symptom-free
A third person has inactive SPMS without confirmed progression during the past year. That sounds reassuring, and it is. Still, the person lives with fatigue, bladder urgency, leg stiffness, and heat sensitivity.
The absence of new disease activity does not erase established nerve damage. Treatment therefore focuses on symptom control, regular exercise with planned rest, cooling strategies, medication review, and adjustments at work. Stability becomes something to protect rather than proof that support is unnecessary.
Shared lessons from these experiences
People living with SPMS often become expert observers of their own bodies. They learn the difference between an ordinary difficult morning and a genuinely new neurological change. They also learn that asking for help early is usually more useful than waiting until a problem becomes a full-time household resident.
Useful habits may include keeping brief symptom notes, recording falls, saving MRI reports, bringing a family member to important appointments, and requesting rehabilitation before a crisis occurs. A mobility aid used early can conserve energy and prevent injury. Workplace accommodations can preserve employment. Counseling or peer support can provide space to discuss grief, uncertainty, relationships, and changing identity.
Perhaps the most important lesson is that an SPMS label describes the disease, not the whole person. Active, inactive, progressing, and stable are clinical modifiers. They are not grades, achievements, or character assessments.
When to Contact a Healthcare Professional
Contact the MS care team promptly for new or clearly worsening neurological symptoms, especially changes in vision, strength, walking, coordination, speech, sensation, or bladder control. Clinicians may need to check for infection, medication effects, a relapse, or another neurological condition.
Seek emergency care for sudden one-sided weakness, facial drooping, severe chest pain, major breathing difficulty, loss of consciousness, or other symptoms that could indicate a stroke or medical emergency. Do not assume every new symptom is “just MS.”
Conclusion
The central difference between active and inactive SPMS is evidence of recent inflammatory disease activity. Active SPMS includes relapses and/or new MRI lesions. Inactive SPMS includes neither during the period being assessed.
Progression is a separate issue. A person can have inactive SPMS while disability gradually worsens, or active SPMS without measurable progression during a particular year. Because these classifications can change, regular neurological evaluations, functional testing, and appropriate MRI monitoring remain important.
Active SPMS may be treated with DMTs approved for relapsing forms of multiple sclerosis. For inactive SPMS, medication decisions are less straightforward and should balance uncertain benefits against individual risks. In both forms, rehabilitation, symptom treatment, preventive care, emotional support, and practical adaptations can protect independence and quality of life.
